HUMA
Humacyte Inc
NASDAQ: HUMA · HEALTHCARE · BIOTECHNOLOGY
$0.84
+2.66% today
Updated 2026-04-30
Market cap
$178.93M
P/E ratio
—
P/S ratio
87.79x
EPS (TTM)
$-0.26
Dividend yield
—
52W range
$1 – $3
Volume
6.7M
Humacyte Inc (HUMA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-6,603.00%
ROE
-249.80%
ROA
-52.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $6.19M | $-85.42M | -1,121.97% | -1,385.02% | -1,380.67% |
| 2020 | $1.49M | $-66.52M | -3,526.96% | -4,332.66% | -4,461.70% |
| 2021 | $1.26M | $-26.48M | -4,756.77% | -6,429.77% | -2,096.36% |
| 2022 | $1.56M | $-11.96M | -427.48% | -5,404.35% | -764.54% |
| 2023 | $0.00 | $-110.78M | — | — | — |
| 2024 | $0.00 | $-148.70M | — | — | — |
| 2025 | $2.04M | $-40.83M | -736.46% | -5,271.69% | -2,003.58% |